CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited

1:15-cv-00919

Overview

Case Number 1:15-cv-00919
Filing Date 2015-10-13
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

West-Ward Pharmaceuticals Corp. Operating Company

Represented By

5 Attorneys Listed

Lauren Sharkey

Email: lauren.sharkey@lw.com

Michelle R. Ma

UNDELIVERABLE EMAIL 9/6/2017

Kenneth G. Schuler

Email: kenneth.schuler@lw.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

West-Ward Pharmaceuticals International Limited NPE (University / Research)

Represented By

5 Attorneys Listed

Lauren Sharkey

Email: lauren.sharkey@lw.com

Michelle R. Ma

UNDELIVERABLE EMAIL 9/6/2017

Kenneth G. Schuler

Email: kenneth.schuler@lw.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Roxane Laboratories, Inc. Operating Company

Represented By

5 Attorneys Listed

Michelle R. Ma

UNDELIVERABLE EMAIL 9/6/2017

Kenneth G. Schuler

Email: kenneth.schuler@lw.com

Emily C. Melvin

UNDELIVERABLE EMAIL 5/18/17

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Counter Defendant

Vanda Pharmaceuticals Inc. Operating Company

Represented By

9 Attorneys Listed

Ethan Haller Townsend

McDermott Will & Emery LLP

Tel: +1 (302) 485-3911

4th floor, The Nemours Building

Daniel J. Klein

Email: daklein@paulweiss.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Karen Jacobs

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Kira A. Davis

Email: kdavis@durietangri.com

Josephine Young

Email: jyoung@paulweiss.com

Eric A. Stone

Email: estone@paulweiss.com

Nicholas Groombridge

Email: ngroombridge@paulweiss.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 11 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (11): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9138432
Methods for the administration of iloperidone
Filed: 2014-01-08
Issued: 2015-09-22
Active (7.1 yrs remaining)
Expires: 2034-01-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 3

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to May 16, 2016 - filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (E...
Entry #20 • 2016-05-02 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to submit the proposed scheduling order to April 14, 2016 - filed by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 04/13/20...
Entry #14 • 2016-04-13 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to December 28, 2015 - filed by Roxane Laboratories, Inc.. (Moore, David) (Ente...
Entry #8 • 2015-11-20 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Roxane Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806807.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sec) (Entered: 10/14/2015)

Entry #1 • 2015-10-13
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Roxane Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806807.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sec) (Entered: 10/14/2015)

Entry #1 • 2015-10-13
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Roxane Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1806807.) - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sec) (Entered: 10/14/2015)

Entry #1 • 2015-10-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 10/14/2015)

Entry #2 • 2015-10-13
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: 09/30/2025. Thirty Month Stay Deadline: N/A. (sec) (Entered: 10/14/2015)

Entry #3 • 2015-10-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc